Kimia Bioscien.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE285U01025
NSEID:
BSEID: 530313

INR

39.62

0.37 (0.94%)

BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 584

{
  "main_header": {
    "sid": 263659,
    "name": "Kimia Bioscien.",
    "stock_name": "Kimia Bioscien.",
    "full_name": "Kimia Biosciences Ltd",
    "name_url": "stocks-analysis/kimia-bioscien",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "39.62",
    "chg": 0.37,
    "chgp": "0.94%",
    "dir": 1,
    "prev_price": "39.25",
    "mcapval": "187.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530313,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE285U01025",
    "curr_date": "Apr 11, 12:52 PM",
    "curr_time": "00:06 AM",
    "bse_nse_vol": "584 ",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kimia-bioscien-263659-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Kimia Biosciences Faces Technical Shift Amid High Debt and Declining Profits",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-stock-downgraded-to-strong-sell-amid-bearish-technical-indicators-1670494",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/KimiaBioscience_mojoScore_861543.png",
        "date": "2025-04-02 08:05:43",
        "description": "Kimia Biosciences has experienced a recent evaluation adjustment, highlighting a shift in its technical trends. Despite positive quarterly financial results, the company faces challenges such as a high debt-to-equity ratio and declining operating profit, complicating its financial outlook amid underperformance against market indices."
      },
      {
        "title": "Kimia Biosciences Faces Mixed Signals Amid Technical Shift and Profit Growth",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-receives-sell-upgrade-amid-high-debt-and-declining-profit-growth-1575719",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/KimiaBioscience_mojoScore_772696.png",
        "date": "2025-03-25 08:03:52",
        "description": "Kimia Biosciences has recently experienced a change in its evaluation, indicating a shift in technical trends. Despite a year of negative stock performance, the company reported a significant increase in net profit and positive quarterly results, though it faces challenges with a high debt-to-equity ratio and low profitability."
      },
      {
        "title": "Kimia Biosciences Reports Strong Profit Growth Amid High Debt Concerns and Market Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-stock-downgraded-to-strong-sell-amid-high-debt-concerns-1423210",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/KimiaBioscience_mojoScore_682498.png",
        "date": "2025-03-18 08:02:49",
        "description": "Kimia Biosciences has recently adjusted its evaluation, reflecting strong financial performance with a significant increase in net profit for the third quarter of FY24-25. Despite this growth, the company faces challenges due to high debt levels and declining operating profit over the past five years, raising concerns about its long-term stability."
      },
      {
        "title": "Kimia Biosciences Reports Strong Profit Growth Amid High Debt Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-receives-sell-upgrade-amid-high-debt-and-declining-profitability-1213023",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/KimiaBioscience_mojoScore_595538.png",
        "date": "2025-03-06 08:01:49",
        "description": "Kimia Biosciences has recently adjusted its evaluation, reflecting strong financial performance with a notable net profit growth of 183.85% for Q3 FY24-25. However, the company faces challenges due to high debt levels and declining operating profit trends, despite outperforming the broader market over the past year."
      },
      {
        "title": "Kimia Biosciences Reports Strong Profit Growth Amid High Debt Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-downgraded-to-strong-sell-amid-high-debt-and-profitability-concerns-1148474",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/KimiaBioscience_mojoScore_560948.png",
        "date": "2025-02-28 18:35:11",
        "description": "Kimia Biosciences has recently experienced a change in evaluation, reflecting its current market dynamics. The company reported impressive third-quarter financial performance, with a significant increase in net profit. However, it faces challenges from a high debt burden and declining operating profit over the past five years, raising concerns about its long-term strength."
      },
      {
        "title": "Kimia Biosciences Reports Significant Profit Growth Amid High Debt Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-reports-183-85-net-profit-growth-amid-high-debt-concerns-1133826",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/KimiaBioscience_mojoScore_545292.png",
        "date": "2025-02-27 19:00:14",
        "description": "Kimia Biosciences has recently experienced an evaluation adjustment, highlighting its strong financial performance, including a notable net profit growth of 183.85% over the last quarter. Despite impressive operating metrics, the company grapples with a high debt-to-equity ratio, indicating potential long-term challenges."
      },
      {
        "title": "Kimia Biosciences Shows Technical Indicator Shifts Amid Market Resilience",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kimia-biosciences-technical-trend-shifts-from-bearish-to-mildly-bullish-amid-stock-price-increase-1112768",
        "imagepath": "",
        "date": "2025-02-25 10:27:32",
        "description": "Kimia Biosciences, a microcap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting notable shifts in its technical indicators. The company's current price stands at 48.66, slightly above the previous close of 48.00, with a 52-week high of 58.40 and a low of 34.37. \n\nIn terms of technical metrics, the MACD indicates a mildly bullish stance on a weekly basis, while the monthly perspective shows a mildly bearish trend. The Bollinger Bands are consistently bullish on both weekly and monthly charts, suggesting a positive price movement. Additionally, the KST reflects a mildly bullish trend weekly and bullish monthly, indicating a potential upward momentum in the stock's performance.\n\nWhen comparing Kimia Biosciences' returns to the Sensex, the company has shown resilience. Over the past week, it recorded a return of 4.51%, contrasting with a decline of 1.74% in t..."
      },
      {
        "title": "Kimia Biosciences Reports Strong Profit Growth Amid High Debt Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kimia-biosciences-downgraded-to-strong-sell-amid-high-debt-concerns-1080338",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/KimiaBioscience_mojoScore_508221.png",
        "date": "2025-02-21 18:11:40",
        "description": "Kimia Biosciences has recently experienced an evaluation adjustment, reflecting its complex financial situation. The company reported strong third-quarter results with significant net profit growth, but it also grapples with a high debt burden and low profitability metrics, raising concerns about its long-term financial stability."
      },
      {
        "title": "Kimia Biosciences Reports Strong Financial Results, Highlights Growth in Key Metrics for December 2024",
        "link": "https://www.marketsmojo.com/news/result-analysis/kimia-biosciences-reports-514-5-increase-in-profit-before-tax-for-december-2024-1011754",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/KimiaBioscience_quaterlyResult_448079.png",
        "date": "2025-02-14 12:23:57",
        "description": "Kimia Biosciences has announced its financial results for the quarter ending December 2024, highlighting significant growth in key metrics. Profit Before Tax reached Rs 3.18 crore, while Profit After Tax was Rs 4.57 crore. The company also reported its highest Operating Profit in five quarters at Rs 5.00 crore."
      }
    ],
    "total": 23,
    "sid": "263659",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/kimia-biosciences-263659"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 31(4) & (5) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations 2011 For The Financial Year Ended March 31 2025",
      "datetime": "04-Apr-2025",
      "details": "Disclosure from the promoter of the Company on behalf of other co-promoters and PAC",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2025",
      "details": "Closure of Trading Window from 01st April 2025",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
      "datetime": "06-Mar-2025",
      "details": "Intimation for issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Kimia Biosciences Faces Technical Shift Amid High Debt and Declining Profits

2025-04-02 08:05:43

Kimia Biosciences has experienced a recent evaluation adjustment, highlighting a shift in its technical trends. Despite positive quarterly financial results, the company faces challenges such as a high debt-to-equity ratio and declining operating profit, complicating its financial outlook amid underperformance against market indices.

Kimia Biosciences Faces Mixed Signals Amid Technical Shift and Profit Growth

2025-03-25 08:03:52

Kimia Biosciences has recently experienced a change in its evaluation, indicating a shift in technical trends. Despite a year of negative stock performance, the company reported a significant increase in net profit and positive quarterly results, though it faces challenges with a high debt-to-equity ratio and low profitability.

Kimia Biosciences Reports Strong Profit Growth Amid High Debt Concerns and Market Challenges

2025-03-18 08:02:49

Kimia Biosciences has recently adjusted its evaluation, reflecting strong financial performance with a significant increase in net profit for the third quarter of FY24-25. Despite this growth, the company faces challenges due to high debt levels and declining operating profit over the past five years, raising concerns about its long-term stability.

Kimia Biosciences Reports Strong Profit Growth Amid High Debt Concerns

2025-03-06 08:01:49

Kimia Biosciences has recently adjusted its evaluation, reflecting strong financial performance with a notable net profit growth of 183.85% for Q3 FY24-25. However, the company faces challenges due to high debt levels and declining operating profit trends, despite outperforming the broader market over the past year.

Kimia Biosciences Reports Strong Profit Growth Amid High Debt Concerns

2025-02-28 18:35:11

Kimia Biosciences has recently experienced a change in evaluation, reflecting its current market dynamics. The company reported impressive third-quarter financial performance, with a significant increase in net profit. However, it faces challenges from a high debt burden and declining operating profit over the past five years, raising concerns about its long-term strength.

Kimia Biosciences Reports Significant Profit Growth Amid High Debt Concerns

2025-02-27 19:00:14

Kimia Biosciences has recently experienced an evaluation adjustment, highlighting its strong financial performance, including a notable net profit growth of 183.85% over the last quarter. Despite impressive operating metrics, the company grapples with a high debt-to-equity ratio, indicating potential long-term challenges.

Kimia Biosciences Shows Technical Indicator Shifts Amid Market Resilience

2025-02-25 10:27:32

Kimia Biosciences, a microcap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting notable shifts in its technical indicators. The company's current price stands at 48.66, slightly above the previous close of 48.00, with a 52-week high of 58.40 and a low of 34.37. In terms of technical metrics, the MACD indicates a mildly bullish stance on a weekly basis, while the monthly perspective shows a mildly bearish trend. The Bollinger Bands are consistently bullish on both weekly and monthly charts, suggesting a positive price movement. Additionally, the KST reflects a mildly bullish trend weekly and bullish monthly, indicating a potential upward momentum in the stock's performance. When comparing Kimia Biosciences' returns to the Sensex, the company has shown resilience. Over the past week, it recorded a return of 4.51%, contrasting with a decline of 1.74% in t...

Kimia Biosciences Reports Strong Profit Growth Amid High Debt Concerns

2025-02-21 18:11:40

Kimia Biosciences has recently experienced an evaluation adjustment, reflecting its complex financial situation. The company reported strong third-quarter results with significant net profit growth, but it also grapples with a high debt burden and low profitability metrics, raising concerns about its long-term financial stability.

Kimia Biosciences Reports Strong Financial Results, Highlights Growth in Key Metrics for December 2024

2025-02-14 12:23:57

Kimia Biosciences has announced its financial results for the quarter ending December 2024, highlighting significant growth in key metrics. Profit Before Tax reached Rs 3.18 crore, while Profit After Tax was Rs 4.57 crore. The company also reported its highest Operating Profit in five quarters at Rs 5.00 crore.